recast-jats-buildd8e1462159jitcJ Immunother Cancer40425Journal for ImmunoTherapy of CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltds40425-019-0639-463910.1186/s40425-019-0639-431234936/jitc/7/1/158.atomCorrectionCorrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureAbdel-WahabNoha12SafaHoussein3AbudayyehAla4JohnsonDaniel H.3TrinhVan Anh3ZobniwChrystia M.3LinHeather5WongMichael K.3AbdelrahimMaen6GaberA. Osama6Suarez-AlmazorMaria E.1DiabAdi3l 0000 0001 2291 4776grid.240145.6Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA 0000 0004 0621 6144grid.411437.4Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt 0000 0001 2291 4776grid.240145.6Department of Melanoma Medical OncologyThe University of Texas MD Anderson Cancer Center Houston TX USA 0000 0001 2291 4776grid.240145.6Section of Nephrology, Division of Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA 0000 0001 2291 4776grid.240145.6Department of BiostatisticsThe University of Texas MD Anderson Cancer Center Houston TX USA 0000 0004 0445 0041grid.63368.38Houston Methodist Hospital Houston TX USA adiab@mdanderson.org 1220192462019181120191811201924620197115814620191462019© The Author(s).2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: ‘We are grateful to Mohsin Shah from the Department of Emergency Medicine at The University of Texas MD Anderson Cancer Center for assisting in study selection, and to Gregory F. Pratt from the Research Medical Library and Erica Goodoff, from the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for their valuable contributions.

publisher-imprint-nameBioMed Centralvolume-issue-count1issue-article-count0issue-toc-levels0issue-pricelist-year2019issue-copyright-holderThe Author(s)issue-copyright-year2019article-contains-esmNoarticle-numbering-styleUnnumberedarticle-registration-date-year2019article-registration-date-month6article-registration-date-day13article-toc-levels0toc-levels0volume-typeRegularjournal-productArchiveJournalnumbering-styleUnnumberedarticle-grants-typeOpenChoicemetadata-grantOpenAccessabstract-grantOpenAccessbodypdf-grantOpenAccessbodyhtml-grantOpenAccessbibliography-grantOpenAccessesm-grantOpenAccessonline-firstfalsepdf-file-referenceBodyRef/PDF/40425_2019_Article_639.pdfpdf-typeTypesettarget-typeOnlinePDFissue-typeRegulararticle-typeErratumjournal-subject-primaryMedicine & Public Healthjournal-subject-secondaryOncologyjournal-subject-secondaryImmunologyjournal-subject-collectionMedicineopen-accesstrue

Maria E. Suarez-Almazor and Adi Diab contributed equally to this work.

The original article can be found online at 10.1186/s40425-019-0585-1

Correction to: J Immunother Cancer (2019) 7:106

https://doi.org/10.1186/s40425-019-0585-1

Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: ‘We are grateful to Mohsin Shah from the Department of Emergency Medicine at The University of Texas MD Anderson Cancer Center for assisting in study selection, and to Gregory F. Pratt from the Research Medical Library and Erica Goodoff, from the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for their valuable contributions.

Reference Abdel-Wahab N , et al . Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer. 2019;7:106 doi:10.1186/s40425-019-0585-1 6469201